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Abstract: The production of pancreatic β cells is the most challenging step for curing diabetes using
next-generation treatments. Adult pancreatic endocrine cells are thought to be maintained by the
self-duplication of differentiated cells, and pancreatic endocrine neogenesis can only be observed
when the tissue is severely damaged. Experimentally, this can be performed using a method named
partial duct ligation (PDL). As the success rate of PDL surgery is low because of difficulties in
identifying the pancreatic duct, we previously proposed a method for fluorescently labeling the
duct in live animals. Using this method, we performed PDL on neurogenin3 (Ngn3)-GFP transgenic
mice to determine the origin of endocrine precursor cells and evaluate their potential to differentiate
into multiple cell types. Ngn3-activated cells, which were marked with GFP, appeared after PDL
operation. Because some GFP-positive cells were aligned proximally to the duct, we hypothesized
that Ngn3-positive cells arise from the pancreatic duct. Therefore, we next developed an in vitro
pancreatic duct culture system using Ngn3-GFP mice and examined whether Ngn3-positive cells
emerge from this duct. We observed GFP expressions in ductal organoid cultures. GFP expressions
were correlated with Ngn3 expressions and endocrine cell lineage markers. Interestingly, tuft cell
markers were also correlated with GFP expressions. Our results demonstrate that in adult mice,
Ngn3-positive endocrine precursor cells arise from the pancreatic ducts both in vivo and in vitro
experiments indicating that the pancreatic duct could be a potential donor for therapeutic use.
Keywords: Ngn3; pancreatic duct; endocrine cell; PDL; organoid culture; tuft cell
1. Introduction
The pancreas is an organ that serves two vital roles, exocrine and endocrine functions,
which help digestion and regulate blood glucose, respectively. The exocrine part comprises
acinar cells and a ductal system that secretes digestive enzymes and drains into the duode-
num. The endocrine compartment of the pancreas consists of islets of Langerhans, which
are composed of five types of endocrine cells: α cells, β cells, δ cells, ε cells, and PP cells.
These cells secrete glucagon, insulin, somatostatin, ghrelin, and pancreatic polypeptide,
respectively [1]. A deficiency in β cells results in diabetes mellitus, for which effective
curative treatment has not been established. One promising therapy is transplantation of
endocrine cells as a substitute for islet cells. However, the generation of β cells either from
embryonic stem cells or induced pluripotent stem cells remains challenging because the
culture conditions for terminal differentiation have not been well-established [2].
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To find other sources of pancreatic stem cells with the potential to become functional
β cells, researchers searched for adult stem cells in the adult pancreas [3]. However, the
β-cell turnover rate is slow, and pancreatic regeneration can only be observed when the
tissue is severely damaged [4]. In contrast, β cells dynamically repopulate in response to
systemic increases in insulin during aging [5], pregnancy [6], obesity [7], and genetic insulin
resistance [8], but the origin of these newly produced β cells is controversial. One group
showed that pre-existing β cells are the major source of new β cells during adult life [4,9].
The other group suggested that β cells form in the adult by transdifferentiation of pancreatic
acinar tissues [10]. Furthermore, another group showed that β cells can be generated from
endogenous progenitors present in pancreatic ducts [11]. The mechanisms leading to
replacement of the endogenous β-cell pool have been studied using chemical [12–14],
genetic [15], and surgical methods such as partial pancreatomy [16] and partial duct
ligation (PDL) [17].
PDL is a suitable model for mimicking human conditions that promote neoplasia;
wide use of this model has provided novel insights into β cell formation. However, the
outcomes of PDL appear to vary between laboratories, and some groups showed that
PDL operation leads to a large increase in the β cell mass [11,15,17–21], whereas other
groups failed to detect new β cells arising from the PDL pancreas [22–24]. The discrepancy
in these results is attributed to the success rate of the operation, as performing PDL is
difficult. To overcome this problem, we established a new technique for PDL using a
simple imaging approach [25]. We examined whether endocrine progenitor cells emerge
from the pancreatic duct after PDL by introducing neurogenin3 (Ngn3)-GFP mice [26], as
Ngn3 is a well-established marker of endocrine progenitor cells [27]. By tracing the GFP
expression after a PDL treatment, we hypothesized that regenerating ductal cells could
give rise to endocrine cell lineages. To examine this hypothesis, we introduced a ductal
organoid culture system to examine whether Ngn3-positive cells emerge accompanied by
endocrine markers as described by Huch et al. in 2013 [19]. To the best of our knowledge,
this is the first study to demonstrate that pancreatic-ductal-derived cells can differentiate
into endocrine lineages.
2. Results
2.1. Observation of Ngn3-Positive Cells in the Ligated Part of the Pancreas at 3, 5, 6, and 21 Days
after Surgery
First, we performed PDL at the tail region of the pancreas in Ngn3-GFP mice. Ngn3-
positive endocrine precursor cells, marked by GFP, were first observed in the ligated
pancreas 3 days after PDL surgery (day 3, Figure 1B). GFP signals were also found in the
tissues on days 5, 6, and 21 (Figure 1C–F), although we did not detect any GFP signals
in the sham-operated pancreas (Figure 1A). GFP signals were observed outside of the
lining of CK19-positive pancreatic ductal cells (Figure 1B–E). Moreover, we observed some
GFP-positive cells in CK19-positive pancreatic ductal cells (Figure 1D, arrows). To examine
whether Ngn3-positive cells express a definitive marker for islet hormones, we performed
immunohistochemistry analysis but did not detect hormones such as insulin, glucagon, or
somatostatin in Ngn3-positive cells on day 6 (data not shown).




Figure 1. Monitoring GFP expression in pancreatic sections after partial duct ligation (PDL) using Ngn3-GFP transgenic 
mice. The tail region of the pancreas was ligated and examined for GFP expression using anti-GFP antibodies (green). 
Pancreatic ducts were identified using anti-CK19 antibodies (red). GFP expression was not detected in the sham-operated 
tail region of the pancreas (A). GFP signals appeared at around day 3 and gradually increased until day 6 after PDL surgery 
(B–E). The average number of GFP-positive cells in one micrograph is shown as a bar graph (F, n = 3). Ngn3-positive cells 
were often detected proximal to CK19-positive ducts after PDL surgery (arrows) (bar: 100 µm). 
2.2. Generation of Pancreatic Ductal Organoids from Ngn3-GFP Mice 
Because we observed temporal expansion of Ngn3-GFP-positive cells after PDL from 
the proximal region of CK19-positive ducts, we hypothesized that GFP-positive cells arose 
from the pancreatic ducts. To clarify the emergence of endocrine progenitor cells from 
pancreatic ducts, we generated pancreatic ductal organoids from Ngn3-GFP transgenic 
mice. We first observed cell proliferation around the edge of the duct on day 2 of culture, 
and continuous expansion of the organoid was observed (Figure 2A–D). On day 4, we 
performed immunostaining of the organoids with CK19 antibodies and found that most 
organoids expressed CK19 (Figure 2E,F). In contrast, amylase, a marker of acinar cells, 
was not observed (Figure 2G), nor were insulin, glucagon, or somatostatin (Supplemen-
tary Materials Figure S2). 
Figure 1. Monitoring GFP expression in pancreatic sections after partial duct ligation (PDL) using Ngn3-GFP transgenic
mice. The tail region of the pancreas was ligated and examined for GFP expression using anti-GFP antibodies (green).
Pancreatic ducts were identified using anti-CK19 antibodies (red). GFP expression was not detected in the sham-operated
tail region of the pancreas (A). GFP signals appeared at around day 3 and gradually increased until day 6 after PDL surgery
(B–E). The average number of GFP-positive cells in one micrograph is shown as a bar graph (F, n = 3). Ngn3-positive cells
were often detected proximal to CK19-positive ducts after PDL surgery (arrows) (bar: 100 µm).
2.2. Generation of Pancreatic Ductal Organoids from Ngn3-GFP Mice
Because we obser t poral expansion of Ngn3-GFP-positive cells after PDL from
the proximal region f -positive ducts, we hypothesized that GFP-positive cells arose
from the pancreatic cts. o clarify the emergence of endocrine progenitor cells from
pancreatic ducts, we generated pancreatic ductal organoids from Ngn3-GFP transgenic
mice. We first observed cell proliferation around the edge of the duct on day 2 of culture,
and continuous expansion of the organoid was observed (Figure 2A–D). On day 4, we
performed immunostaining of the organoids with CK19 antibodies and found that most
organoids expressed CK19 (Figure 2E,F). In contrast, amylase, a marker of acinar cells, was
not observed (Figure 2G), nor were insulin, glucagon, or somatostatin (Supplementary
Materials Figure S2).
N xt, we examined whether Ngn3-GFP-positive cells were present in the ductal
organoids. We detected no GFP signal before day 5 in the organoid cultures (Figure 3A).
GFP signals were first observed in the organoids at around days 7–9 (Supplementary
Materials Figure S3, Figure 3B). The number of GFP-positive cells increased within the
same organoid up to day 11 (Figure 3B–D).
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Figure 2. Generation and characterization of ductal organoid from the pancreas. Pancreatic ducts were dissected from the 
pancreas and embedded in Matrigel covered with organoid media to start organoid culture (A). After 2 days, the sheared 
end of the duct started proliferating and then formed organoids (B–D, arrowheads). Immunohistochemical analysis of 
organoids after 4 days of culture. All cells within the organoids expressed cytokeratin 19 (CK19), a selective ductal marker 
(E,F). An acinar cell-specific marker, amylase, was not detected on day 4 (G). (bars: A–D, 500 µm; E, 100 µm; F, 50 µm; G, 
30 µm). 
Next, we examined whether Ngn3-GFP-positive cells were present in the ductal or-
ganoids. We detected no GFP signal before day 5 in the organoid cultures (Figure 3A). 
GFP signals were first observed in the organoids at around days 7–9 (Supplementary Ma-
terials Figure S3, Figure 3B). The number of GFP-positive cells increased within the same 
organoid up to day 11 (Figure 3B–D). 
 
Figure 3. Emergence of Ngn3-GFP-positive cells in pancreatic ductal organoid. Ductal organoids were generated from 
Ngn3-GFP mice, and GFP expression, representing Ngn3 expression, was monitored. Ngn3-GFP expression was not ob-
served on day 5 (A), but first appeared around days 7–9 of culture (B). GFP-positive cells started increasing thereafter (B–
D, arrowheads) (bar: 250 µm). 
2.3. Ngn3-Positive Cells Can Differentiate into Endocrine Cells 
To clarify the properties of Ngn3-expressing organoids, we extracted total RNA on 
day 11 of organoid culture as described in the Materials and Methods. RNA-Seq was per-
formed to compare gene expression between organoids that expressed GFP signals and 
those that did not (Figure 4A). We confirmed that organoids showing a GFP signal pre-
dominantly expressed higher mRNA levels of Ngn3, demonstrating the reliability of the 
data (Figure 4B). The expression of transcription factors such as NeuroD1 and Isl1 was 
Figure 2. Generation and characterization of ductal organoid from the pancreas. Pancreatic ducts were dissected from the
pancreas and embedded in Matrigel covered with organoid media to start organoid culture (A). After 2 days, the sheared end
of the duct started proliferating and then formed organoids (B–D, arrowheads). Immunohistochemical analysis of organoids
after 4 days of culture. All cells within the organoids expressed cytokeratin 19 (CK19), a selective ductal marker (E,F). An
acinar cell-specific marker, amylase, was not detected on day 4 (G). (bars: A–D, 500 µm; E, 100 µm; F, 50 µm; G, 30 µm).
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Figure 3. Emergence of Ngn3-GFP-positive cells in pancreatic ductal organoid. Ductal organoids were generated from
Ngn3-GFP mice, and GFP expression, representing Ngn3 expression, was monitored. Ngn3-GFP expression was not
observed on day 5 (A), but first appeared around days 7–9 of culture (B). GFP-positive cells started increasing thereafter
(B–D, arrowheads) (bar: 250 µm).
2.3. Ngn3-Positive Cells Can Differentiate into Endocrine Cells
To clarify the properties of Ngn3-expressing organoids, we extracted total RNA on
day 11 of organoid culture as described in the Materials and Methods. RNA-Seq was
performed to compare gene expression between organoids that expressed GFP signals
and those that did not (Figure 4A). We confirmed that organoids showing a GFP signal
predominantly expressed higher mRNA levels of Ngn3, demonstrating the reliability of
the data (Figure 4B). The expression of transcription factors such as NeuroD1 and Isl1 was
elevated in Ngn3-expressing organoids compared to organoids that did not express Ngn3
(Figure 4C,D). We observed no significant increase in the gene expression of glucagon
(Gcg) but detected Gcg expression in both the Ngn3(-) and Ngn3(+) fractions (Figure 4E).
The expression of endocrine cell markers, such as Sst, Ghrl, and Chga, was significantly
elevated in the Ngn3(+) fraction (Figure 4F–H, q < 0.05). Interestingly, the expression of
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molecules involved in taste information transmission, such as Trpm5, Gnat3, and Pou2f3,
was also significantly elevated (Figure 4I–K, q < 0.05). To confirm the RNA-seq results, we
performed RT-PCR with specific primers for each analyzed gene (Figure 4L). These results
showed that pancreatic-duct-derived cells can differentiate into both the enteroendocrine
and tuft cell lineages.
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of the wells with or without organoids expressing GFP. Organoids were d fined as Ngn3(+) if GFP-positive cells were
observed on day 1. In contrast, or i it t FP signal were defined as Ngn3(−). (B–K) Transcriptome analysis
was performed with total RNAs extracte fro ay 11 organoids that expressed either Ngn3(−) and Ngn3(+) cells. Ngn3,
NeuroD, and Isl1, key regulators of the endocrine lineage; ature endocrine markers Sst, Ghrl, and Ghga; and taste-related
genes Trpm5, Gnat3, and Pou2f3, were significantly expressed in Ngn3-GFP-expressing organoids (n = 3, * q < 0.05). The
gene Gcg, encoding GLP-1 and GLP-2, was expressed in both Ngn3(−) and Ngn3(+) cells (E). Results of RNA-Seq analysis
were confirmed by RT-PCR (L). Cont, negative control without cDNA.
3. Discussion
Ngn3 is t i ti factor es ential for endocrine differ ntiation and often used
as a marker to s i e lineage specification [27]. We demonstrated through both
in vivo in vitro experiments tha Ngn3-positive endocrine p ecursor ell emerge from
the pancreatic duct. Ngn3-GFP mice do not express GFP in the normal adult p ncreas
(Figure 1A, Supplementary Materials Figure S1); however, we showed that GFP-positive
cells emerge after PDL treatment in vivo or in organoid culture using dissected pancreatic
ducts. Immunohistochemistry (Figure 2, Supplementary Materials Figure S2) and tran-
scriptome analysis (data not shown) suggested that pancreatic organoids in which most
of the cells showed immunoreactivity to CK19 do not initially express any components
derived from mature acinar or endocrine cells. However, after 3–5 days in vivo or 7–9 days
in organoid culture, we observed the emergence of GFP-positive cells, indicating Ngn3
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was expressed. We further demonstrated by transcriptome analysis that pancreatic-duct-
derived Ngn3-positive cells have the potential to differentiate into endocrine lineages.
Our results are consistent with the report that Ngn3-expressing cells derived from human
pluripotent stem cells are endocrine progenitor cells and can be further differentiated to
produce insulin, glucagon, and somatostatin [28]. Therefore, the molecular mechanism
underlying endocrine cell differentiation of the pancreas appears to be similar between
human and mouse, and thus can be extrapolated from a mouse model to human use for
providing donor cells for regeneration therapies.
Through our data, we showed that pancreatic duct cells have the potential to ded-
ifferentiate to become Ngn3-expressing endocrine progenitor cells (Figure 5), although
it should be further examined whether the phenomenon that we observed was through
stem cells or direct conversion from duct cells to Ngn3-positive cells. There have been
several hypotheses regarding the existence and location of adult stem- or progenitor-like
cells that can give rise to functional β cells. Cell ablation methods using chemical [12–14],
genetic [15], and surgical techniques [16,17] have been used to test the regeneration ac-
tivity of the adult mouse pancreas, which is capable of yielding new insulin-producing
β cells. Although the PDL technique is widely used to induce pancreatic regeneration,
in β-cell neogenesis followed by PDL, the origin of β cells remains controversial. Our
newly established PDL method that can easily visualize the pancreatic duct helped us to
avoid simultaneous ligation of blood vessels or nerve fibers, thus increased the reliability
of PDL operation [25,29]. PDL on Ngn3-GFP transgenic mice using this method revealed
that GFP-positive cells often emerged proximal to the reorganizing ducts. Therefore, we
hypothesized that Ngn3-positive cells arise, at least in part, from the pancreatic duct when
the pancreas is damaged. As most Ngn3-positive cells did not overlap with the pancreatic
duct, we predicted that Ngn3-positive cells can only convert into endocrine cells after
they move out of the pancreatic duct. This idea was previously suggested by Shih et al.,
who showed that ductal markers and Ngn3 expression are almost exclusive [30]. Further
studies are needed to determine whether Ngn3-positive cells arise from pancreatic stem
cells or from the dedifferentiation of functional cells in the pancreas. Several reports sup-
port the idea of acinar-to-ductal transdifferentiation, proposing that acinar cells also have
plasticity [31–34]. Our data, both in vivo and in vitro, show that Ngn3-positive cells can be
produced from pancreatic ductal cells; however, our results do not exclude the possibility
of acinar-to-ductal transdifferentiation.
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Notably, we found that the expression of molecules specific to tuft cells such as
Trpm5, Gnat3, and Pou2f3 [35], was significantly upregulated in correlation with the ex-
pression of Ngn3. These results suggest that pancreatic ducts can differentiate into multiple
cell lineages including tuft and endocrine cells. Both cell types emerged from the same
Ngn3-GFP-positive cell fractions, indicating that cell differentiation occurs simultaneously,
although lineage tracing experiments are needed to confirm this. It is natural to observe tuft
cell differentiation in organoid culture because these cells were reported to be present in the
pancreatic duct in mice and humans [35,36]. Recent studies showed that tuft cells trigger
type 2 immunity after parasite infection or when stimulated by succinate [37–40]. Based on
previous studies, we predicted that pancreatic ducts also possess a self-defense function,
likely to protect the tissue from microorganisms and irritants confronted by ductal tuft cells
when the duodenal reflux or pancreatitis occurs. In our future studies, we will establish a
culture method to obtain fully mature endocrine or tuft cells that can respond to nutrients
or hazardous substances. Our in vitro culture methods utilizing Ngn3-GFP transgenic mice
will help to optimize the conditions for cell differentiation, as cell maturation appears to
occur simultaneously. There is, however, a limitation to this study: organoids generated
from pancreatic duct might not always recapitulate in vivo to produce Ngn3-expressing
progenitor cells as we expected. It is important to find the appropriate culture condition
for organoids to differentiate into certain lineages.
In conclusion, we showed both in vivo and in vitro that the pancreatic duct can
produce endocrine progenitor cells that express Ngn3. The organoid culture generated
from the pancreatic duct will be a good model to study endocrine cell differentiation as well
as to understand how the pancreas is regenerated after injury. In the future, the pancreatic
duct organoid will potentially be a new source for endocrine cells for therapeutic usage as
well as in vitro drug screening system to create new drugs for pancreatic cell regeneration.
4. Materials and Methods
4.1. Animals
All animals used in this study were obtained, housed, cared for, and used in ac-
cordance with the “Guiding Principles in the Care and Use of Animals” published by
the Animal Care Committee of Tokyo University of Agriculture (Tokyo, Japan, Ethics
identification number: 290084, 28 September 2017). Ngn3-GFP mice were described previ-
ously [26]. Mice bred on a C57BL/6 background and crossed with C57BL/6 or ICR mice
were maintained on a 12 h light cycle with access to food and water ad libitum.
4.2. PDL after Cholyl-Lysyl-Fluorescein Injection
A combination anesthetic was prepared from medetomidine (0.3 mg/kg), midazolam
(4.0 mg/kg), and butorphanol (5.0 mg/kg). Medetomidine was purchased from Zenoaq
(Tokyo, Japan). Midazolam was purchased from Sandoz (Tokyo, Japan). Butorphanol
was purchased from Meiji Seika Pharma (Tokyo, Japan). Chlorhexidine gluconate was
purchased from Sumitomo Dainippon Pharma (Osaka, Japan). Cholyl-lysyl-fluorescein was
purchased from Corning (Corning, NY, USA). PDL surgeries were performed as previously
described [25].
4.3. Immunohistochemistry
The following antibodies were used: anti-pancreatic alpha amylase (ab21156, Abcam,
Cambridge, U.K.), anti-insulin (sc-7839, Santa Cruz Biotechnology, Dallas, TX, USA),
anti-somatostatin 28 (ab22682, Abcam), anti-glucagon (ab92517, Abcam), and anti-GFP
(Rockland Immunochemicals, Gilbertsville, PA, USA). Rabbit anti-CK19 antibodies were
a gift from Dr. Atsushi Miyajima (The university of Tokyo) [41,42]. PDL-administered
pancreas or pancreatic organoids from Ngn3-GFP mice (n = 3, respectively) were fixed in
4% paraformaldehyde in phosphate-buffered saline and embedded in O.C.T. compound
(Sakura Finetek, Torrance, CA, USA). Frozen sections (12 µm) were prepared and incubated
in 0.3% Triton X-100 and 2% donkey serum for 1 h, followed by incubation with the primary
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antibodies overnight at 4 ◦C. Next, the sections were incubated with secondary antibodies
(Alexa Fluor 555 or 594 IgG; Invitrogen, Carlsbad, CA, USA) and counterstained with DAPI
(Nacalai Tesque, Kyoto, Japan).
4.4. Organoid Culture
Ngn3-GFP mouse pancreatic organoids were prepared as previously described [19,43]
with minor modifications. Briefly, the pancreas was dissected and minced into pieces,
followed by incubation with digestion solution (wash medium with 0.125 mg/mL collage-
nase IV, 0.125 mg/mL dispaseII, and 0.1 mg/mL DNase I) for 1 h at 37 ◦C. Isolated ducts
were embedded in Matrigel covered with the culture medium (5% R-spondin2-conditioned
medium, 5% Noggin-conditioned medium, 2% B27 supplement (without vitamin A),
100 ng/mL recombinant human FGF10 (Peprotech, Rocky Hill, NJ, USA), 50 ng/mL re-
combinant mouse epidermal growth factor (Peprotech), 10 mM nicotinamide (FUJIFILM
WAKO, Osaka, Japan), 1 mM N-acetylcysteine (Sigma Aldrich, St. Louis, MO, USA), and
10 nM recombinant human [Leu15]-gastrin1 (Sigma Aldrich) in the basal medium). Every
2–3 days, the medium was replaced with fresh medium.
4.5. RNA-Seq Analysis
Total RNA was extracted from the organoids using ISOGEN (Nippon Gene, Tokyo,
Japan). The quality and quantity of the extracted RNA were determined using a spec-
trophotometer (Nanodrop 2000, Thermo Fisher Scientific, Waltham, MA, USA) and an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). Library prepa-
ration was performed using a NEBNext Ultra RNA Library Prep Kit for Illumina (New
England Biolabs, Ipswich, MA, USA) according to the manufacturer’s protocol. The precise
concentration of the libraries was determined using a KAPA Library Quantification Kit
(Kapa Biosystems, Wilmington, MA, USA). All libraries were diluted to a concentration of
10 nM and mixed in equal amounts. The library mixture was sequenced by 1 × 100 base
pair single-read sequencing on an Illumina HiSeq 2500 (Illumina, San Diego, CA, USA).
Reads in FASTQ format were generated using bcl2fastq2 conversion software (Illumina,
version 2.18). The read data were submitted to the DDBJ Read Archive (accession number:
DRA007996). Adapter sequences and the initial 13 bases in each read were removed using
CLC Genomics Workbench 10 software (Qiagen, Hilden, Germany). The cleaned read data
were mapped to the mouse reference genome (GRCm38.p6) retrieved from the Ensembl
genome browser (https://www.ensembl.org/index.html, accessed on 22 November 2018).
Mapping parameters were as follows: mismatch cost, 2; insertion cost, 3; deletion cost, 3;
length fraction, 0.8; and similarity fraction, 0.8.
4.6. Statistical Analysis
Differentially expressed genes of Ngn3-GFP-expressing organoids and control organoids
were identified with significant thresholds of a fold-change ≥ |1.5| and false discovery
rate adjusted p-value (q-value) < 0.05 using a generalized linear model approach using the
CLC Genomics Workbench built-in tools Differential Expression for RNA-Seq.
4.7. Reverse Transcription (RT)-PCR
Organoids were collected after 11 days, and total RNA was extracted using ISOGEN.
The SuperScript III First-Strand Synthesis System for RT-PCR (Thermo Fisher Scientific) was
used to generate cDNA. RT-PCR was performed using primer pairs against the gene of in-
terest (primers are shown in Table S1). RT-PCR was performed as previously described [44]
using primers specific for enteroendocrine and tuft cell markers (Supplementary Materials
Table S1).
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